おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Angiotech Pharmaceuticals
company
About
Angiotech is a Vancouver, British Columbia pharmaceutical company.
- 1001 - 5000
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Health Care,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 1989
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Angiotech Pharmaceuticals has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Mar 21, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 21, 2017 | Series Unknown | — | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Angiotech Pharmaceuticals is funded by 4 investors.
Cathay Venture
and Fung Shing Investments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
China Orient Asset Management (International) Holding
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
